Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Value, Access and Regulatory Strategy Workshop
Session 3: Early Dialogue Between Regulators and HTA (and Payers & Patients)
Session Chair(s)
Mira Pavlovic, DrMed, MD, MS
- HTA Expert /Director/HTA Professor
- NDA Advisory Services, Medicines Development and Training (MDT) Services, France
Speaker(s)
HTA Bodies Cooperation on Early Dialogues: Recent Advances
François Meyer, MD
- Advisor to the President, International Affairs
- French National Authority for Health (HAS), France
Enhancing the Dialogue Beyond RCTs
Byron Jones
- Executive Director
- Statistical Methodology and Consulting Group, Novartis Pharma AG, Switzerland
The Imperfect Study Design – How to Deal with It?
Stefan Lange, MD
- Deputy Director
- Institute for Quality and Efficiency in Health Care (IQWiG), Germany